Further trials of nifurtimox in mucocutaneous leishmaniasis
- 1 January 1981
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 75 (3) , 335-337
- https://doi.org/10.1016/0035-9203(81)90086-9
Abstract
At a dosage level of 8 to 10 mg/kg body-weight daily for 120 days nifurtimox was associated with clinical healing of cutaneous leishmaniasis in five of eight patients. At a dosage level of 20 mg/kg body-weight daily for 10 days in six of 10 patients the skin ulcer healed. Results and the reasons why both schemes are impracticable are briefly discussed.Keywords
This publication has 1 reference indexed in Scilit:
- Nifurtimox in the treatment of South American leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1979